Pages with the fewest revisions
Jump to navigation
Jump to search
Showing below up to 50 results in range #9,791 to #9,840.
- Renovascular disease pathophysiology (1 revision)
- Renovascular disease physical examination (1 revision)
- Renovascular disease primary prevention (1 revision)
- Renovascular disease risk factors (1 revision)
- Renovascular disease screening (1 revision)
- Renovascular disease secondary prevention (1 revision)
- Renovascular disease surgery (1 revision)
- Renovo, plc. (1 revision)
- Renzapride (1 revision)
- René Spitz (1 revision)
- Repaglinide (patient information) (1 revision)
- Replication protein A1 (1 revision)
- Replication protein A2 (1 revision)
- Replication protein A3 (1 revision)
- Repolarization (1 revision)
- Reporting results (1 revision)
- Repotrectinib (1 revision)
- Representational systems (NLP) (1 revision)
- Representative agent (1 revision)
- Repressor lexA (1 revision)
- Reprimo (1 revision)
- Reproduction (1 revision)
- Reproductive endocrinology (1 revision)
- Reproductive endocrinology and infertility (1 revision)
- Reproductive system (1 revision)
- Reproductive system disease (1 revision)
- Reproductive technology (1 revision)
- Reptile (1 revision)
- Repugnant market (1 revision)
- Research (1 revision)
- Research Defence Society (1 revision)
- Research ethics (1 revision)
- Research funding (1 revision)
- Resection (1 revision)
- Reserpine (patient information) (1 revision)
- Residency (medicine) (1 revision)
- Resiniferatoxin (1 revision)
- Resistant starch (1 revision)
- Resistivity (1 revision)
- Resistor (1 revision)
- Reslivizumab (1 revision)
- Resolution (1 revision)
- Resonator (1 revision)
- Respiration (physiology) (1 revision)
- Respiration organ (1 revision)
- Respiratory Disturbance Index (1 revision)
- Respiratory acidosis case study one (1 revision)
- Respiratory acidosis future or investigational therapies (1 revision)
- Respiratory bronchiole (1 revision)
- Respiratory disease (patient information) (1 revision)